These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 600086)

  • 21. [Biosynthetic actinomycins from aurantin-producing Actynomyces].
    Kuznetsova VS; Orlova TI; Silaev AB
    Antibiotiki; 1971 Jan; 16(1):18-21. PubMed ID: 4101731
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of aurantin on Act. species no. 2, which produces this antibiotic].
    Nefelova MV; Egorov NS
    Antibiotiki; 1971 Jun; 16(6):496-9. PubMed ID: 4106999
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of whale oil and vegetable oils as carbon source during biosynthesis of bruneomycin].
    Ol'khovatova OL; Il'chenko GB; Kochetkova GV
    Antibiotiki; 1970 Oct; 15(10):932-6. PubMed ID: 5530626
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative characteristics of toxic substances produced by some bacteria, fungi and Actinomycetes].
    Egorova SA; Kuimova TF
    Antibiotiki; 1973 Sep; 18(9):854-8. PubMed ID: 4761960
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antineoplastic effect of antibiotics 3002 and 3853].
    Rossolimo OK; Maksimova TS; Sveshnikova MA; Ol'khovatova OL; Kovsharova IN
    Antibiotiki; 1971; 16(4):320-2. PubMed ID: 5109579
    [No Abstract]   [Full Text] [Related]  

  • 26. [Characteristics of actinomycetes antagonists of the Azureus section].
    Preobrazhenskaia TP
    Antibiotiki; 1966 Sep; 11(9):849-61. PubMed ID: 5996880
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antibiotic substances inducing the formation of mature phage particles in a lysogenic culture of Micrococcus lysodeikticus and their production by Actinomycetes].
    Terekhova LP
    Antibiotiki; 1966 Oct; 11(10):901-6. PubMed ID: 5997594
    [No Abstract]   [Full Text] [Related]  

  • 28. [Systematic position, variability and antibiotic properties of the producer of antineoplastic antibiotic tavromycetin].
    Ivanitskaia LP; Upiter GD; Sveshnikova MA; Gauze GF
    Antibiotiki; 1966 Nov; 11(11):973-6. PubMed ID: 4871096
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of methyl group labelled methionine as a source of Cl4 and H3 for the preliminary production of labelled olivomycin by biosynthesis].
    Karpov VL; Romanova LG
    Antibiotiki; 1971 Mar; 16(3):229-32. PubMed ID: 5558683
    [No Abstract]   [Full Text] [Related]  

  • 30. [Works of Soviet scientists in the field of research of new antibiotics].
    Gauze GF
    Antibiotiki; 1967 Nov; 12(11):963-71. PubMed ID: 4174395
    [No Abstract]   [Full Text] [Related]  

  • 31. [Selection of a culture of Actinomyces coeruleorubidus, the producer of the antitumor antibiotic rubomycin].
    Saburova TP; Lapchinskaia OA; Krugliak EB
    Antibiotiki; 1974 Jun; 19(6):509-14. PubMed ID: 4849684
    [No Abstract]   [Full Text] [Related]  

  • 32. [Microbiology and medical industry].
    Tuzhilkin IM
    Antibiotiki; 1970 Jul; 15(7):579-86. PubMed ID: 4920967
    [No Abstract]   [Full Text] [Related]  

  • 33. [Study of sensitivity to antibiotics in cultures of Anacystis nidulans and Chlorella sp. in relation to their possible use as tests in selection of new biologically active compounds from Actinomycetes].
    Ivanitskaia LP; Manafova NA
    Antibiotiki; 1968 Dec; 13(12):1104-9. PubMed ID: 4180805
    [No Abstract]   [Full Text] [Related]  

  • 34. [Isolation and physicochemical properties of the antineoplastic antibiotic 1719].
    Konstantinova NV; Grishin IA; Kovsharova IN; Tolstykh IV; Myshentseva TM
    Antibiotiki; 1972 Aug; 17(8):680-3. PubMed ID: 4674504
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of agar and gelatin on formation of antibiotics by actinomycetes].
    Rogozhina AP; Brians'ka AM; Golovata IaA
    Mikrobiol Zh; 1968; 30(1):79-82. PubMed ID: 5733590
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of some antineoplastic antibiotics in combination with culture fluids of Actinomycetes on transplanted animal tumors].
    Biriukov EA
    Antibiotiki; 1968 Nov; 13(11):1021-2. PubMed ID: 4181224
    [No Abstract]   [Full Text] [Related]  

  • 37. [Actinoxanthin. Purification and biological properties].
    Khokhlov AS; Cherches BZ; Reshetov PD; Smirnova GM; Koloditskaia TA
    Izv Akad Nauk SSSR Biol; 1970; 5():755-63. PubMed ID: 5498403
    [No Abstract]   [Full Text] [Related]  

  • 38. [Carminomycin: a new antineoplastic anthracycline].
    Brazhnikova MG; Zbarskiĭ VB; Kudinova MK; Murav'eva LI; Ponomarenko VI
    Antibiotiki; 1973 Aug; 18(8):678-81. PubMed ID: 4776401
    [No Abstract]   [Full Text] [Related]  

  • 39. [Microbiological characteristics of actinomycetes, growth inhibitors of malignant tumour tissue cultures].
    Kaliuzhna LD; Frolov AF
    Mikrobiol Zh; 1965; 27(5):10-6. PubMed ID: 5868316
    [No Abstract]   [Full Text] [Related]  

  • 40. [Isolation and physicochemical properties of berromycin, a new antineoplastic antibiotic].
    Kudinova MK; Borisova VN; Petukhova NM; Brazhnikova MG
    Antibiotiki; 1972 Aug; 17(8):689-93. PubMed ID: 4628944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.